231 related articles for article (PubMed ID: 29464274)
21. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of ultrasound-guided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma.
Sui G; Luo Q; Du J; Teng D; Wang H
J Med Ultrason (2001); 2019 Apr; 46(2):217-222. PubMed ID: 30564948
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
25. Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy.
Filippiadis DK; Gkizas C; Chrysofos M; Siatelis A; Velonakis G; Alexopoulou E; Kelekis A; Brountzos E; Kelekis N
Int J Hyperthermia; 2018 Nov; 34(7):1077-1081. PubMed ID: 29202667
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
27. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma.
An TJ; Arellano RS
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):281-288. PubMed ID: 33078234
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.
Liang P; Wang Y; Zhang D; Yu X; Gao Y; Ni X
J Urol; 2008 Sep; 180(3):844-8; discussion 848. PubMed ID: 18635230
[TBL] [Abstract][Full Text] [Related]
31. Computed Tomography-Guided Microwave Ablation of Cystic Renal Cell Carcinoma: Assessment of Technique and Complications.
Zhou W; Herwald SE; Arellano RS
J Vasc Interv Radiol; 2021 Apr; 32(4):544-547. PubMed ID: 33795074
[TBL] [Abstract][Full Text] [Related]
32. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
33. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
34. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
35. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
36. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
[TBL] [Abstract][Full Text] [Related]
38. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
39. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation.
Moreland AJ; Ziemlewicz TJ; Best SL; Hinshaw JL; Lubner MG; Alexander ML; Brace CL; Kitchin DR; Hedican SP; Nakada SY; Lee FT; Abel EJ
J Endourol; 2014 Sep; 28(9):1046-52. PubMed ID: 24846329
[TBL] [Abstract][Full Text] [Related]
40. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
